Overexpression of SLC7A6 within HCC tumors was associated with a median 45.7-month overall survival of patients compared to 70.5 months in the low-expression cohort (p < 0.05, HR = 1.57 (1.1–2.24), Figure 5C). The gene discussed is SLC7A6; the disease is hepatocellular carcinoma.